Karen DeSalvo Net Worth

The estimated Net Worth of Karen B De Salvo is at least $337 Thousand dollars as of 10 November 2018. Karen Salvo owns over 634 units of Welltower stock worth over $81,570 and over the last 7 years he sold WELL stock worth over $0. In addition, he makes $255,033 as Independent Director at Welltower.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Karen DeSalvo WELL stock SEC Form 4 insiders trading

Karen has made over 1 trades of the Welltower stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 634 units of WELL stock worth $81,570 on 10 November 2018.

The largest trade he's ever made was exercising 634 units of Welltower stock on 10 November 2018 worth over $81,570. On average, Karen trades about 30 units every 0 days since 2017. As of 10 November 2018 he still owns at least 634 units of Welltower stock.

You can see the complete history of Karen Salvo stock trades at the bottom of the page.

Karen DeSalvo biography

Dr. Karen B. DeSalvo serves as Independent Director of the Company. Dr. DeSalvo is a physician executive and adjunct professor of medicine at the University of Texas at Austin Dell Medical School where she has served since January 2018 and a member of the National Academy of Medicine. From 2014 to 2017, she served as Acting Assistant Secretary for Health at the U.S. Department of Health and Human Services and as National Coordinator for Health Information Technology. From 2011 to 2014, she served as the Health Commissioner for the City of New Orleans. Dr. DeSalvo’s experience in medical and public health leadership, health care technology, health care delivery and health care innovation make her an important addition to the Board.

What is the salary of Karen DeSalvo?

As the Independent Director of Welltower, the total compensation of Karen DeSalvo at Welltower is $255,033. There are 13 executives at Welltower getting paid more, with Shankh Mitra having the highest compensation of $5,728,140.

How old is Karen DeSalvo?

Karen DeSalvo is 54, he's been the Independent Director of Welltower since 2018. There are 8 older and 9 younger executives at Welltower. The oldest executive at Welltower Inc. is Jeffrey Donahue, 73, who is the Lead Independent Director.

What's Karen DeSalvo's mailing address?

Karen's mailing address filed with the SEC is 4500 DORR STREET, , TOLEDO, OH, 43615.

Insiders trading at Welltower

Over the last 7 years, insiders at Welltower have traded over $2,063,553 worth of Welltower stock and bought 3,587 units worth $192,115 . The most active insiders traders include Timothy J Naughton, R Scott Trumbull, and Philip L Hawkins. On average, Welltower executives and independent directors trade stock every 56 days with the average trade being worth of $1,023,748. The most recent stock trade was executed by Kenneth J Bacon on 4 June 2024, trading 1,800 units of WELL stock currently worth $187,038.

What does Welltower do?

health care reit, inc. is now welltower™ welltower™ is a recognized leader in providing consistent, low-cost capital to fund health care infrastructure and real estate. our business structure as a publically traded reit (nyse:hcn) provides us with opportunities to fund innovative solutions designed to keep patients out of higher cost, higher acuity settings while delivering better treatment at lower cost. global demographic and social trends, notably the aging of the population, require vast investments and infrastructure development. the devastating impact of dementia on people and their families demands new solutions. together with our operating partners, we’re creating environments that help our partners meet the challenges of this complicated and rapidly changing market. welltower™ partners with some of the most innovative health systems and seniors housing operators to grow their platforms and support the evolution of health care. together with our partners, we seek to drive

Complete history of Karen Salvo stock trades at Humana and Welltower

Welltower executives and stock owners

Welltower executives and other stock owners filed with the SEC include:

• Shankh Mitra,
  Chief Executive Officer, Chief Investment Officer, Director
• Timothy McHugh,
  Chief Financial Officer, Executive Vice President
• Shankh S. Mitra,
  CEO, Chief Investment Officer & Director
• Matthew McQueen,
  Senior Vice President, General Counsel, Corporate Secretary
• Timothy G. McHugh,
  Exec. VP & CFO
• Matthew Grant McQueen J.D.,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Ayesha M. Menon,
  Sr. VP of Wellness Housing and Devel.
• Jeffrey Donahue,
  Lead Independent Director
• Sharon Oster,
  Independent Director
• Sergio Rivera,
  Independent Director
• Kenneth Bacon,
  Non-Executive Chairman of the Board
• Johnese Spisso,
  Independent Director
• Kathryn Sullivan,
  Independent Director
• Karen DeSalvo,
  Independent Director
• Diana Reid,
  Director
• Philip Hawkins,
  Director
• Nicholas Rumanes,
  Vice President - Head of Development
• Ryan Rothacker,
  Vice President - Portfolio Management & Operations
• Justin Skiver,
  Senior Vice President, Global Head of Seniors Housing
• Ayesha Menon,
  Senior Vice President - Strategic Investments
• John Olympitis,
  Sr. VP & Head of Corp. Devel.
• Pam Byrne,
  Sr. VP & Head of Human Capital
• Mary Ellen Pisanelli,
  Sr. VP of Legal & Admin.
• Krishna Soma,
  VP of Corp. Fin.
• Joshua T. Fieweger,
  Sr. VP & Chief Accounting Officer
• John F. Burkart,
  Exec. VP & COO
• Thomas J Derosa,
  Chairman & CEO
• John Goodey,
  Chief Financial Officer
• Mercedes Kerr,
  EVP-Business Development
• Gary Whitelaw,
  Director
• R Scott Trumbull,
  Director
• Judith C Pelham,
  Director
• Timothy J Naughton,
  Director
• Geoffrey G Meyers,
  Director
• John F. Burkart,
  EVP-Chief Operating Officer
• Andrew Gundlach,
  
• Ade J. Patton,
  
• Dennis G Lopez,
  
• Joshua Fieweger,
  SVP, Chief Accounting Officer